The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases

Cancer Biotherapy and Radiopharmaceuticals

Volumn 20, Issue 4, 2005, Pages 450-456

  Zubeldia, Jose M ^a   Bednarczyk, Edward M ^a   Baker, John G ^a   Nabi, Hani A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Colorectal cancer; Cost analysis; CT; FDG PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DIAGNOSTIC ACCURACY; HEALTH CARE COST; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT OUTCOME; COLORECTAL TUMOR; DECISION TREE; ECONOMICS; INSTRUMENTATION; LIVER TUMOR; METASTASIS; METHODOLOGY; PATHOLOGY; RADIOTHERAPY;

COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DECISION TREES; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 24044535754     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2005.20.450     Document Type: Article

References (24)

1. Landis S, Murray T, Beiden S, et al. Cancer Statistics. Cancer J Clin 1998;48:6.
2. Galandiuk S, Wieand, H., Moertel, C., et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surgery. 1992;174:27-32.
3. Steele GJ, Bleday, R, Mayer, RJ, et al. A propective evaluation of hepatic resection for colorectal carcinoma metasteses to the liver: Gastrointestinal tumor study group 6584. J Clin Oncol 1991;9:1105.
4. Sugarbaker PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology 1990; 176:621.
5. Kronawitter U, Kemeny N, Heelan R, et al. Evaluation of chest-computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 1999;86:229.
6. Delbeke D, Vitola, V, Sandler, MP, et al. Staging recurent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196.
7. Zhuang H, Sinha, P, Pourdehand, M, et al. The role of positron emision tomography with fluorine-18-deoxygloucose in identifying colorectal cancer metastases to liver. Nucl Med Comm 2000;21:793.
8. Ogunbiyi OA, Flanagan, FL, Dehdashti, F, et al. Detection of recurent and metastatic colorectal cancer: Comparison of poitron emission tomography and computed tomography. Ann Surg Oncol 1997;4:613.
9. Schiepers C, Penninckx, F, De Vadder, N, et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging. Eur J Surg Oncol 1995;21:517.
10. Valk PE, Abella-Columna, E, Hasemann, MK, et al. Whole-body PET imaging with F-18 fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999; 134:503.
11. Arulampalam T, Costa D, Visvikis D, et al. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl Med 2001;28:1758.
12. Huebner RH, Park KC, Shepherd, JE, et al. A meta-analysis of the literature for whole-body FDG-PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41:1177.
13. Thoeni RF, Rogalla, P. CT evaluation of carcinomas in the colon and rectum. Semin Ultrasound CT MRI. 1995;16:112.
14. Thoeni RF. Colorectal cancer, radiologie staging. Radiol Clin N Am 1997;35:457.
15. Rohren E, Paulson E, Hagge R, et al. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 2002;27:550.
16. Montravers F, Grahek D, Kerrou K, et al. Detection of recurrent colorectal carcinoma by 18F-FDG: Comparison of the clinical performance of FDG-PET and FDG-CDET. Nucl Med Comm 2004;24:105.
17. DATA [computer program]. Version 3.0. Williamstown, MA: TreeAge Software, 1996.
18. Public Use Data Files. Center for Medicare and Medicaid Services, 1999.
19. Kinkel K, Lu Y, Both M, et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR Imaging, PET): A meta-analysis. Radiology 2002;224: 748.
20. Park KC, Schwimmer, J, Shepherd, JE, et al. Decision analysis for the cost-effective management of recurrent colorectal cancer. Ann Surg 2001;233:310.
21. 18F-fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 1994;81:1666.
22. Ruers TJ, Langenhoff, BS, Neelman, N, et al. Value of positron emission tomography with F-18 fluorodeoxyglucose in patients with colorectal liver metastases. A prospective study. J Clin Oncol 2002;20:388.
23. Fernandez F, Drebin J, Linehan D, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438.
24. Miller E, Lerman H, Gutman M, et al. The clinical impact of camera-based positron emission tomography imaging in patients with recurrent colorectal cancer. Invest Radiol 2004;39:8.